Comparison of fasle negative rates of urea breath test in patients after PCAB-based eradication therapy for clarithromycin resistance H.pylori

Comparison of fasle negative rates of urea breath test in patients after PCAB-based eradication therapy for clarithromycin resistance H.pylori - Efficacy of UBT after PCAB-based H.pylori eradication

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019628

Enrollment

Registered

2015-11-05

Start date

2015-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

urea breath test, stool H.pylori antigen test

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with clarythromycin resistance H.pylori infection who take eradication treatment. Patients who test efficacy of H.pylori eradication therapy by urea breath test. Patients who give a written informed consent.

Exclusion criteria

Exclusion criteria: Pregnancy or lactation. Past history of allergy for the drugs used in H.pylori eradication. Severe liver dysfunction, Severe renal dysfunction, Severe heart dysfunction. Patients who are disqualified for the study by physicians.

Design outcomes

Primary

Measure	Time frame
False-negative rate of urea breath test	—

Countries

Japan

Contacts

Public ContactSoichiro Sue

Yokohama City University Hospital Gastroenterology

ssue@yokohama-cu.ac.jp045-261-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026